The Clinical Effect of Shenkang Injection Combined with Irbesartan Used for Patients with Diabetic Nephropathy at Early Stage

Objective To explore the clinical effect of shenkang injection combined with irbesartan used for patients with diabetic nephropathy at early stage.Methods 84 cases of patients with diabetic nephropathy at early stage as studied object were randomly divided into experimental group and control group.Two groups were given base therapy such as hypoglycemic drugs and insulin,control group was added with shenkang injection,and experimental group were added with combined with irbesartan on base of control group.Results The therapy of two groups was smooth,and there was no serious sidereaction happened during therapy stage.After therapy,the UAER,Cr and BUN in two groups were turned well significantly(allP0.01),but the indexes in experimental group were turned significantly better than in control group(all P0.01).Conclusion For patients with diabetic nephropathy at early stage,therapy of shenkang injection combined with irbesartan show high effectively and safety,so it deserved considering in clinical work.